alexa Hutchinson Mark Rowland | OMICS International

Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Hutchinson Mark Rowland

Centre of Excellence for Nanoscale Biophotonics, University of Adelaide, Adelaide, South Australia


 Professor Hutchinson is an ARC Australian Research Fellow and is the Director of the ARC Centre of Excellence for Nanoscale BioPhotonics (CNBP;

He is also a Professor within the School of Medical Sciences at the University of Adelaide.

Professor Hutchinson returned to the University of Adelaide in 2009 as an NHMRC CJ Martin Research Fellow, and established the Neuroimmunopharmacology research laboratory. From 2005 to 2009 Mark worked in the world leading laboratory of Prof Linda Watkins in the Center for Neuroscience at the University of Colorado at Boulder. Here he pioneered with Prof Watkins the research which has led to the discovery of novel drug activity at innate immune receptors.

Mark’s research has implicated the brain immune-like cells in the action of drugs of dependence and the negative side effects of pain treatments.

Mark has published over 100 papers in journals and refereed conference proceedings.

The CNBP is an ARC Centre of Excellence with $38M of funding committed for 7 years, headquartered at The University of Adelaide, with nodes at Macquarie University, Sydney and the RMIT, Melbourne. We are partnered with universities and companies in Europe, the US and China, as well as other  Australian institutions.  

The CNBP has a mission to "Discover new approaches to measure nano-scale  dynamic phenomena in living systems".  

The Scientific Aims of the CNBP are to:  

1. Reach the limits of light-based measurement within complex and dynamic  biological environments;  

2. Exploit physics and multiple scales -- nanoscale to macro -- using  photons to bridge from nanomaterial to devices;  

3. Create smart, tailored interfaces between these nanoscale systems and  the biochemical environment;  

4. Establish new forms of measurement assays that can operate within  living organisms;

5. Deploy these assays to address identified challenges in systems  including the embryo, brain and blood vessels; and  

6. Seek molecular level insight into the mechanisms, processes and functionalities in these biological systems.  






Mark is the theme leader of the Institute for Photonics and Advanced Sensing, Biological Sensing and Medical Diagnostics. He is a member of the Science Technology  Australia board and the convener of the Neuro and Behavioural Pharmacology special interest group of ASCEPT.

Research Interest

  brain immune-like cells in the action of drugs of dependence and the negative side effects of pain treatments.

Global Speakers in the subject

Global Experts in the subject